Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review

  • ID: 1314929
  • SWOT Analysis
  • 46 pages
  • GlobalData
  • Abeona Therapeutics Inc
1 of 5

FEATURED COMPANIES

  • Baxter International Inc
  • Biocon Ltd
  • BMG Pharma Srl
  • Camurus AB
  • Circle33 LLC
  • Galera Therapeutics Inc
  • MORE
Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated virus. Abeona is also develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) gene therapy for treatment of infantile Batten disease (INCL), and ABO-301 (AAV-FANCC) for Fanconi anemia (FA) disorder and ABO-302 for rare blood diseases. The company has partnership with for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in Dallas, Texas, the US.

Abeona Therapeutics Inc Key Recent Developments

May 14, 2018: Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
May 11, 2018: Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights
May 08, 2018: Abeona Therapeutics Announces Upcoming Presentations
Apr 02, 2018: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Mar 16, 2018: Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Baxter International Inc
  • Biocon Ltd
  • BMG Pharma Srl
  • Camurus AB
  • Circle33 LLC
  • Galera Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Abeona Therapeutics Inc - Key Facts
  • Abeona Therapeutics Inc - Key Employees
  • Abeona Therapeutics Inc - Key Employee Biographies
  • Abeona Therapeutics Inc - Major Products and Services
  • Abeona Therapeutics Inc - History
  • Abeona Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Abeona Therapeutics Inc - Business Description
  • Abeona Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Abeona Therapeutics Inc - Strengths
  • Abeona Therapeutics Inc - Weaknesses
  • Abeona Therapeutics Inc - Opportunities
  • Abeona Therapeutics Inc - Threats
  • Abeona Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Abeona Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 14, 2018: Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
  • May 11, 2018: Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights
  • May 08, 2018: Abeona Therapeutics Announces Upcoming Presentations
  • Apr 02, 2018: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
  • Mar 16, 2018: Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights
  • Feb 02, 2018: Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium
  • Nov 15, 2017: Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights
  • Oct 16, 2017: Abeona Announces $13.85M Grant from Leading Sanfilippo Syndrome Foundations for Clinical Development of MPS III Gene Therapies
  • Oct 04, 2017: Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio
  • Oct 04, 2017: Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Abeona Therapeutics Inc, Key Facts
  • Abeona Therapeutics Inc, Key Employees
  • Abeona Therapeutics Inc, Key Employee Biographies
  • Abeona Therapeutics Inc, Major Products and Services
  • Abeona Therapeutics Inc, History
  • Abeona Therapeutics Inc, Subsidiaries
  • Abeona Therapeutics Inc, Key Competitors
  • Abeona Therapeutics Inc, Ratios based on current share price
  • Abeona Therapeutics Inc, Annual Ratios
  • Abeona Therapeutics Inc, Annual Ratios (Cont...1)
  • Abeona Therapeutics Inc, Annual Ratios (Cont...2)
  • Abeona Therapeutics Inc, Interim Ratios
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Abeona Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Abeona Therapeutics Inc, Performance Chart (2013 - 2017)
  • Abeona Therapeutics Inc, Ratio Charts
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Alder Biopharmaceuticals Inc
  • Baxter International Inc
  • Biocon Ltd
  • BMG Pharma Srl
  • Camurus AB
  • Circle33 LLC
  • Galera Therapeutics Inc
  • Grifols SA
  • Jazz Pharmaceuticals Plc
  • LFB SA
  • Midatech Pharma US Inc
  • Synedgen Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll